Prevalence and risk factors of glaucoma among the population of Ganja city, Azerbaijan

Cover Page

Cite item


Aim. To determine prevalence of glaucoma among adult urban population on example of Ganja city of the Azerbaijan Republic.

Methods. In city polyclinics primary examination was performed in 6585 people that makes 3% of adults of the population. Among the examined patients the indications for thorough in-patient work-up were determined in 250 patients. The diagnosis of glaucoma was confirmed in 220 patients (90 males and 130 females). The prevalence of glaucoma was determined (in % of the examined patients). The patients were divided into groups according to their gender, age, education, family history, presence of eye and internal diseases. A group with the lowest prevalence of glaucoma was chosen as a reference, and the other groups were termed as study groups for the assessment of relative risk of glaucoma development.

Results. Glaucoma was revealed in 2.7±0.28% of males and 3.9±0.34% of females (p <0.05). Morbidity rate in women is higher compared to men. Risk factors of glaucoma are: intraocular pressure >21 mm Hg - 3.8±0.24%, compromised family history - 4.7±0.27%, diabetes mellitus - 3.66±0.24%, myopia - 5.7±0.3%, cataract - 10.0±0.4%, arterial hypertension - 11.9±0.4%. General morbidity rate of glaucoma among patients older than 20 years old is 3.45±0.23%. The lowest prevalence of glaucoma was determined among people of 20-29 years old (0.9±0.22%; 95% confidence interval 0.40-1.33). Prevalence of glaucoma increases with age of the examined patients. Statistically significant increase of prevalence of glaucoma is detected among population aged 40 years or older (3.3±0.49% of people aged 40-49 years) and reaches its maximum among people aged 60-69 years (12.2±1.56%).

Conclusion. Prevalence of glaucoma among population of Ganja aged 20 years and older is comparatively high; differentiated monitoring of intraocular pressure with risk factors taken into account is reliable for early detection of glaucoma.

About the authors

K F Agaeva

Azerbaijan State Institute of Doctors’ Improvement named after A. Aliyev

Author for correspondence.

N O Mamedova

Azerbaijan State Institute of Doctors’ Improvement named after A. Aliyev


T F Nabiev

Ganja City Ophthalmologic Hospital



  1. Глаукома. Национальное руководство. Под ред. Е.А. Егорова. М.: ГЭОТАР-Медиа. 2013; 824 с.
  2. Рустамова Н.М. Возрастной риск первичной инвалидности вследствие глазных заболеваний в Азербайджане. Рос. офтальмол. ж. 2012; 5 (1): 65-68.
  3. Стентон Г. Медико-биологическая статистика. М.: Практика. 1999; 459 с.
  4. Abdull M.M., Gilbert C.C., Evans J. Primary open angle glaucoma in Northen Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmology. 2015; 15: 111. doi: 10.1186/s12886-015-0097-9
  5. El-Assal, Foulds J., Dobson S., Sanders R. A comparative study of glaucoma referrals in Southeast Scotland: effect of the new general ophthalmic service contract, Eyecare integration pilot programme and NICE guidelines. BMC Ophthalmology. 2015; 15: 172. doi: 10.1186/s12886-015-0161-5
  6. Glen F., Crabb D. Living with glaucoma: a qualitative study of functional implications and patients coping behaviours. BMC Ophthalmology. 2015; 15: 128. doi: 10.1186/s12886-015-0119-7
  7. He J., Zou H., Lee R. et al. Prevalence and risk factors of primary open-angle glaucoma in city of Eastern China: a population - based study in Pudoug New district, Shanghai. BMC Ophthalmology. 2015; 15: 134. doi: 10.1186/s12886-015-0124-x
  8. Kyari F., Entekume G., Rabiu M. et al. A population - based survey of the prevalence and types of glaucoma in Nigeria: result from the Nigeria National blindness and visual impairment survey. BMC Ophthalmology. 2015; 15: 176. doi: 10.1186/s12886-015-0160-6
  9. NICE (National Institute for Health and care excellence) guideline. Clinical guideline. 2009. (access date: 15.04.2016).

© 2017 Agaeva K.F., Mamedova N.O., Nabiev T.F.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies